Close MenuClose
Close Menu

Justin A . Tolman, PharmD, PhD

Associate Professor

Pharmacy

Justin Tolman

Contact

School of Pharmacy and Health Professions
Pharmacy
Pharmacy Faculty
Pharmacy Sciences
Faculty - Pharmacy, OT, PT
Graduate School
Pharmaceutical Sciences (Master of Science)
HLSB - Hixson Lied Science Building

Justin A . Tolman, PharmD, PhD

Associate Professor

Pharmacy

Department

Pharmacy Sciences

Position

Associate Professor

Books

  • Elsevier
    Tolman, J.A., Huslig, M. Aerosol Dosage Forms: Pulmonary Drug Delivery. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A. (Eds)
    1st Edition, p. 225-239 2013

Articles

  • AAPS PharmSciTech
    Vora D, Kincaid AE, Tolman J, Chauhan H. Characterization and Systemic Delivery of Dibenzoylmethane via the Intranasal Route. AAPS PharmSciTech. 2021;22(1):30. 2021
  • Journal of Pharmaceutical Sciences
    Indapurkar, Amruta, Henriksen, Brian, Tolman, Justin, Fletcher, James Evaluation of triazole-chelated lanthanides as chemically stabile bioimaging agents
    102, p. 2589-2598 2013
  • Elsevier
    Singh, S., Tolman, J.A. Biopolymers. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A.
    1st Edition, p. 139-150 2013
  • Elsevier
    Tolman, J.A., Lambros, M. P., Membrane Transport and Permeation. In Pharmaceutics: Basic Principles and Application to Pharmacy Practice, Dash, A.K., Singh, S., Tolman, J.A. (Eds.).
    1st Edition, p. 307-315 2013
  • Elsevier
    Hedaya, M. A., Tolman, J.A.. Routes of Drug Administration. In Pharmaceutics: basic Principles and Application to Pharmacy Practice. Dash, A.K., Singh, S., Tolman, J.A. (Eds.)
    1st Edition, p. 333-.348 2013
  • Therapeutics and clinical risk management
    Tolman, J. A., Faulkner, M. A. Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
    7, p. 367-375 2011
  • Journal of Central Nervous System Disease
    Faulkner M., Tolman J.A. Safety and Efficacy of Vigabatrin for the Treatment of Infantile Spasms.
    3, p. 199-207 2011
  • Drug Development and Industrial Pharmacy
    Tolman, Justin A., Williams, Robert O.,III Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties
    36, p. 1-30 2010
  • Clinical Medicine Insights: Therapeutics
    Faulkner M., Tolman J.A. Vigabatrin in Refractory Complex Partial Seizures. The Evidence of its Therapeutic Value.
    2, p. 849-856 2010
  • Expert Opinion on Pharmacotherapy
    Tolman, Justin A., Faulkner, Michele A. Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
    10, p. 3077-3089 2009

Presentations

  • Agrawal, P., Arte, K., North, E.J., Tolman, J.A. Expanding Global Tuberculosis Treatment Through a Novel Inhaled Clofazimine Product. Scientific Poster. AAPS 2020 PharmSci 360, American Association of Pharmaceutical Scientists. Virtual 2020
  • Agrawal, P., Arte, K., North, E.J., Tolman, J.A.Improving Global Tuberculosis Treatment through a Novel Inhaled Drug-Device Combination Product. Scientific Poster. Global Health Conference Midwest. Omaha, NE 2020
  • M. Huslig, A. Sabnis R. Fowler, N. Hanson, J. Tolman. An In Vitro Model of Bacterial Pneumonia. Abstract accepted for the 2014 American Association of Pharmaceutical Sciences Annual Meeting and Exposition, San Diego, CA 2014
  • N. Navalkar, D. Patel, J. Tolman. Evaluation of Modified Liquid Impaction Surfaces in the Next generation Impactor (NGI). Abstract published in the Proceedings of the American Association of Pharmaceutical Scientists Annual Meeting. San Antonio, TX 2013
  • M.Huslig, J. Tolman. Characterization of Spray Dried Nanoparticulate Chitosan Using a Novel Nebulizer Nozzle. Abstract published in the Proceedings of the American Association of Pharmaceutical Scientists Annual Meeting. Chicago, IL 2012

Foundation/Association

  • Optimized Dry Powder Formulation and Delivery for Inhaled Clofazimine. Sponsoring Organization: SBIR Phase 1: Topic 051 Creare LLC, Hannover, NH. Funded (# HHSN 2722018000040C). Awarding organization: NIH/NIAID. With Dr. Jeffrey North

Awards

  • Student selected teaching award from the Pharmacy Student Honors Society (Rho Chi)
    Rho Chi Excellence in Teaching Award

Consulting

  • Consultant - Genelex Corporation
    Exernal Consultant
    Consultation on pharmacokinetic principles for improvement of the Algo-Improver Program.
    Genelex Corporation
    2014 - 2014